Short-Term Debt to Capital: INVO Fertility (IVF)

Serving as the primary valuation tool, this price chart on GURU.Markets for INVO Fertility Inc (IVF) reflects the dynamics of a company with a metric of 0.09. The business is vulnerable to disruptions in Asian logistics chains and US sanctions. Profitability is growing through the consistent sale of high-margin components. The model relies on FDA approval and the loyalty of reproductive centers utilizing IVF capsules.

IVF - INVO Bioscience Short-Term Debt to Capital Coefficient over the range 04/29/2025 - 10/31/2026

Analytical breakdowns for invobioscience.com (IVF)

- stock quotes and analyst forecast:
Stock Price INVO Bioscience, Inc.|IVF - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization INVO Bioscience|IVF - Real Price to Acquire Entire Company
- book capitalization information:
Book Value per Share INVO Fertility|IVF - Book Valuation of Business|Market Capitalization to Book Value Ratio invobioscience.com|IVF - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Equity INVO Fertility Inc|IVF - Long-Term Debt to Equity|Short-Term Debt to Capital INVO Fertility|IVF - Company Total Debt Obligations|Debt to Book Value INVO Bioscience|IVF - Long-Term Liabilities|Company Short-Term Debts INVO Fertility|Quick Ratio invobioscience.com
- earnings and market ratios statistics:
IVF - Company Profit
Basic company analysis:INVO Bioscience, Inc. IVF

For INVO Fertility Inc (IVF), which seeks to diversify its narrow profile through the acquisition of regional clinics, the ratio of short-term liabilities to equity serves as an indicator of liquidity and solvency. This metric measures the proportion of debts maturing within one year relative to equity, allowing for an assessment of default risk or expansion potential, which is clearly reflected in the price action of short-term debt to equity.

Competitor analysis for INVO Fertility Inc

Short-Term Debt to Capital BSX|EW - Current Liabilities to Capital|Short-Term Debt to Capital RMD (ResMed Inc.)|PODD - Short-Term Debt to Equity Ratio|Zimmer Biomet Holdings - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient The Cooper Companies, Inc. COO|ALGN: Short-Term Debt to Capital|NuVasive (GMED) - Short-Term Debt to Capital|Short-Term Debt to Equity TransMedics Group Inc|Short-Term Debt to Equity ATEC|Short-Term Debt to Capital AORT|Short-Term Debt to Capital Coefficient Enovis Corp|Integra - Short-Term Debt to Equity Ratio|ESTA (Establishment Labs Inc) - Current Liabilities to Equity|Beta Bionics Inc - Short-Term Debt to Capital|Current Liabilities to Capital iradimed.com|EMBC: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio TNDM|Short-Term Debt to Equity Ratio AXGN|SIBN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Orthofix Medical Inc. (OFIX)|Short-Term Debt to Equity Ratio bioventus.com BVS|Short-Term Debt to Capital KIDS (OrthoPediatrics)|Treace Medical Concepts Inc (TMCI) - Current Liabilities to Capital|Strata Critical Medical Corp - Short-Term Debt to Capital|CARL (Carlsmed Medical) - Short-Term Debt to Capital Ratio|RXST: Short-Term Debt to Capital|CLPT - Short-Term Debt to Capital Coefficient|STXS (Stereotaxis) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Neuronetics Inc. (STIM)|Short-Term Debt to Capital SGHT|Short-Term Debt to Capital orchestrabiomed.com (OBIO)|Short-Term Debt to Equity Anika Therapeutics, Inc. ANIK|inspiremd.com - Short-Term Debt to Equity|ZJYL: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital VANI (Vivani Medical, Inc.)|XTNT: Short-Term Debt to Capital|Current Liabilities to Capital NeuroOne Medical Technologies Corp. (NMTC)|Short-Term Debt to Equity Modular Medical Inc|MYO - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio COCH (Envoy Medical)|Short-Term Debt to Capital Vivos Therapeutics Inc. (VVOS)|Short-Term Debt to Capital NVNO (enVVeno)|Short-Term Debt to Capital Coefficient Sintx Technologies Inc (SINT)|TNON - Short-Term Debt to Equity|Current Liabilities to Equity LFWD|autonomix.com (AMIX) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Bone Biologics Corp.|AXNX (Axonics Modulation Technologies) - Short-Term Debt to Capital|Current Liabilities to Capital Biolase Inc. BIOL|Short-Term Debt to Equity Dynatronics Corporation (DYNT)|paragon28.com - Short-Term Debt to Capital Ratio|INVO Bioscience - Short-Term Debt to Equity Ratio